Jerry Krishnan to United States
This is a "connection" page, showing publications Jerry Krishnan has written about United States.
Connection Strength
1.827
-
Building a new regional home for implementation science: Annual Midwest Clinical & Translational Research Meetings. J Investig Med. 2023 08; 71(6):567-576.
Score: 0.089
-
Yet Another Crack in the Facade of the Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2023 01 01; 207(1):2-4.
Score: 0.087
-
Reply to Albert: Informing Healthcare Decisions with Observational Research Assessing Causal Effects: An American Thoracic Society Statement Not Ready for Implementation. Am J Respir Crit Care Med. 2021 08 01; 204(3):376.
Score: 0.079
-
How Vaccines Work to Prevent Infections. Am J Respir Crit Care Med. 2021 03 15; 203(6):P16-P17.
Score: 0.077
-
National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here? Am J Respir Crit Care Med. 2021 01 15; 203(2):164-167.
Score: 0.076
-
Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 01 01; 203(1):14-23.
Score: 0.076
-
What Will Uncontrolled Asthma Cost in the United States? Am J Respir Crit Care Med. 2019 11 01; 200(9):1077-1078.
Score: 0.070
-
Access to Supplemental Oxygen Therapy: A Crisis. Ann Am Thorac Soc. 2018 07; 15(7):893-894.
Score: 0.064
-
Use of Antibiotics Among Patients Hospitalized for Exacerbations of Asthma. JAMA Intern Med. 2016 09 01; 176(9):1397-400.
Score: 0.056
-
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med. 2013 Feb 01; 187(3):320-6.
Score: 0.043
-
Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD. Clin Pharmacol Ther. 2011 Dec; 90(6):888-92.
Score: 0.040
-
The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012 Jan; 141(1):87-93.
Score: 0.039
-
Con: comparative effectiveness research. More than dollars and cents. Am J Respir Crit Care Med. 2011 Apr 15; 183(8):975-6.
Score: 0.039
-
A call for action: Comparative effectiveness research in asthma. J Allergy Clin Immunol. 2011 Jan; 127(1):123-7.
Score: 0.037
-
Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD. 2010 Jun; 7(3):164-71.
Score: 0.036
-
Follow-up after acute asthma episodes: what improves future outcomes? J Allergy Clin Immunol. 2009 Aug; 124(2 Suppl):S35-42.
Score: 0.034
-
Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006 Sep 15; 174(6):633-8.
Score: 0.028
-
Lessons Learned for the Study of Childhood Asthma from the Centers for Children's Environmental Health and Disease Prevention Research. Environ Health Perspect. 2005 Oct; 113(10):1430-6.
Score: 0.026
-
Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care. JAMA Pediatr. 2024 Nov 01; 178(11):1208-1215.
Score: 0.025
-
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials. NEJM Evid. 2024 Nov; 3(11):EVIDctcs2300291.
Score: 0.025
-
Health Insurance Type and Outpatient Specialist Care Among Children With Asthma. JAMA Netw Open. 2024 Jun 03; 7(6):e2417319.
Score: 0.024
-
Differences in Health Care Utilization for Asthma by Children with Medicaid versus Private Insurance. Popul Health Manag. 2024 Apr; 27(2):105-113.
Score: 0.024
-
Influenza Vaccinations Among Privately and Publicly Insured Children With Asthma. Acad Pediatr. 2023 Sep-Oct; 23(7):1368-1375.
Score: 0.022
-
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma. Am J Respir Crit Care Med. 2023 02 15; 207(4):390-405.
Score: 0.022
-
Addressing Transportation Insecurity Among Patients With Cancer. J Natl Cancer Inst. 2022 12 08; 114(12):1593-1600.
Score: 0.022
-
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 12; 5(12):862-872.
Score: 0.020
-
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021 09 01; 204(5):536-545.
Score: 0.020
-
Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med. 2001 Jul 09; 161(13):1660-8.
Score: 0.020
-
Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation. Ann Am Thorac Soc. 2021 03; 18(3):426-432.
Score: 0.019
-
Electronic Health Records and Pulmonary Function Data: Developing an Interoperability Roadmap. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2021 01; 18(1):1-11.
Score: 0.019
-
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 11 15; 202(10):e121-e141.
Score: 0.019
-
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). Eur Respir Rev. 2020 Sep 30; 29(157).
Score: 0.019
-
Home Oxygen Evaluation by Respiratory Therapists in Patients Hospitalized for COPD Exacerbations: The RIsOTTO Study. Respir Care. 2021 02; 66(2):183-190.
Score: 0.018
-
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 05 01; 201(9):e56-e69.
Score: 0.018
-
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest. 2020 04; 157(4):856-865.
Score: 0.018
-
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers. JAMA Intern Med. 2020 01 01; 180(1):106-115.
Score: 0.018
-
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. Int J Chron Obstruct Pulmon Dis. 2019; 14:2927-2938.
Score: 0.018
-
A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography. Am J Respir Crit Care Med. 2019 09 15; 200(6):721-731.
Score: 0.017
-
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 02; 16(2):161-170.
Score: 0.017
-
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS. Chest. 2019 05; 155(5):908-917.
Score: 0.017
-
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study. Chest. 2019 03; 155(3):519-527.
Score: 0.017
-
Optimizing Home Oxygen Therapy. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2018 12; 15(12):1369-1381.
Score: 0.016
-
Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy. Ann Am Thorac Soc. 2018 10; 15(10):1131-1136.
Score: 0.016
-
Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc. 2017 Dec; 14(12):1779-1785.
Score: 0.015
-
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 09; 50(3).
Score: 0.015
-
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Ann Am Thorac Soc. 2017 May; 14(5):636-642.
Score: 0.015
-
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 03; 49(3).
Score: 0.015
-
Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Respir Med. 2017 02; 123:1-7.
Score: 0.014
-
Care transition interventions for children with asthma in the emergency department. J Allergy Clin Immunol. 2016 12; 138(6):1518-1525.
Score: 0.014
-
Enrolling African-American and Latino patients with asthma in comparative effectiveness research: Lessons learned from 8 patient-centered studies. J Allergy Clin Immunol. 2016 12; 138(6):1600-1607.
Score: 0.014
-
Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 09; 13(9):1490-6.
Score: 0.014
-
Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank Meeting. J Am Coll Cardiol. 2016 08 02; 68(5):517-524.
Score: 0.014
-
Burden of asthma with elevated blood eosinophil levels. BMC Pulm Med. 2016 Jul 13; 16(1):100.
Score: 0.014
-
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med. 2016 06; 4(6):473-526.
Score: 0.014
-
Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary. Value Health. 2016 06; 19(4):440-50.
Score: 0.014
-
An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders. Ann Am Thorac Soc. 2016 Mar; 13(3):S12-21.
Score: 0.014
-
American Thoracic Society and National Heart, Lung, and Blood Institute Implementation Research Workshop Report. Ann Am Thorac Soc. 2015 Dec; 12(12):S213-21.
Score: 0.013
-
Hospitalist attitudes toward the assessment and management of dyspnea in patients with acute cardiopulmonary diseases. J Hosp Med. 2015 Nov; 10(11):724-30.
Score: 0.013
-
Disability and recovery of independent function in obstructive lung disease: the cardiovascular health study. Respiration. 2014; 88(4):329-38.
Score: 0.012
-
An official American thoracic society workshop report: developing performance measures from clinical practice guidelines. Ann Am Thorac Soc. 2014 May; 11(4):S186-95.
Score: 0.012
-
A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci. 2014 Apr; 7(2):164-71.
Score: 0.012
-
Chronic obstructive pulmonary disease readmissions at minority-serving institutions. Ann Am Thorac Soc. 2013 Dec; 10(6):680-4.
Score: 0.012
-
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012 Jul 09; 12:26.
Score: 0.011
-
Comparative effectiveness research in chronic obstructive pulmonary disease. J Comp Eff Res. 2012 Jan; 1(1):71-82.
Score: 0.010
-
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med. 2012 Jan 15; 185(2):152-9.
Score: 0.010
-
Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop. Am J Respir Crit Care Med. 2011 Oct 01; 184(7):848-56.
Score: 0.010
-
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med. 2010 Apr 01; 181(7):752-61.
Score: 0.009
-
Joint task force report: supplemental recommendations for the management and follow-up of asthma exacerbations. Introduction. J Allergy Clin Immunol. 2009 Aug; 124(2 Suppl):S1-4.
Score: 0.009
-
Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs. Am J Med. 2003 Sep; 115(4):298-308.
Score: 0.006
-
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003 May 26; 163(10):1180-6.
Score: 0.006
-
Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Evid Rep Technol Assess (Summ). 2003 Jan; (68):1-6.
Score: 0.005
-
Asthma in older patients: factors associated with hospitalization. Arch Intern Med. 2002 May 27; 162(10):1123-32.
Score: 0.005